Vivitra 440 mg Injection is an anti-HER2 targeted cancer therapy used in patients whose tumors overexpress the HER2 protein. It works by binding to HER2 receptors on cancer cells, blocking their growth signals and activating immune responses to destroy tumor cells.
This injection is commonly prescribed as part of combination chemotherapy or adjuvant therapy in early-stage and metastatic cancers.
Composition
-
Generic Name: Trastuzumab
-
Strength: 440 mg
-
Dosage Form: Lyophilized Powder for Injection
Therapeutic Uses
-
HER2-positive Breast Cancer
-
HER2-positive Metastatic Breast Cancer
-
HER2-positive Gastric (Stomach) Cancer
-
Adjuvant cancer therapy after surgery
How Vivitra 440 mg Injection Works
Trastuzumab binds to HER2 receptors on cancer cells and:
-
Blocks cancer cell growth and division
-
Prevents tumor progression
-
Enhances immune system attack on cancer cells
-
Improves treatment response and survival rates
Dosage & Administration
-
Administered as an intravenous (IV) infusion
-
Dosage depends on body weight, cancer type, and treatment protocol
-
Given under strict oncologist supervision in a hospital or cancer center
Possible Side Effects
-
Fever and chills
-
Fatigue
-
Nausea and vomiting
-
Headache
-
Infusion-related reactions
-
Heart function changes (cardiotoxicity in rare cases)
Patients should undergo regular cardiac monitoring during therapy.
Precautions & Warnings
-
Use only under medical supervision
-
Avoid during pregnancy due to fetal risk
-
Monitor heart function before and during treatment
-
Inform the doctor about existing heart conditions or prior chemotherapy
Storage Instructions
-
Store at 2°C to 8°C in a refrigerator
-
Do not freeze
-
Keep away from light
-
Use only after professional reconstitution
Why Choose Vivitra 440 mg Injection?
-
Effective HER2-targeted cancer therapy
-
Clinically proven to improve survival outcomes
-
Suitable for early-stage and metastatic cancer
-
Reduces tumor growth and recurrence risk
Reviews
There are no reviews yet.